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Introduction 
The use of injections of botulinum toxin type A for 
aesthetic purpose is rapidly growing in the Asian 
population, especially to treat dynamic wrinkles and 
hypertrophy of masseter muscles [1]. A recent trend 
in this targeted population also includes the 
treatment of gummy smile. This condition is 
currently corrected by injections in the levator labii 
superioris alaeque nasi and the levator labii 
superioris [2-5]. Analogous approach is also 
successfully adopted to reduce the nasal alar base 
width during smiling and to correct facial synkinesis 
[6, 7]. The aim of this report is to present an unusual 
complication observed after botulinum toxin type A 
injection for gummy smile associated with nasal alar 
base reduction, which may also potentially occur in 
case of synkinesis treatment. 
 
Case Synopsis 
A 28-year-old woman presented to our outpatient 
clinic complaining about gummy smile associated 
with excessive width of the nasal alar base. This 
condition was highly emphasized while smiling, 
engendering social discomfort and embarrassment 
for the patient (Figure 1A, B). 
The treatment was conducted in accordance with 
our protocol for gummy smile and nasal alar base 
reduction, which includes botulinum toxin type A 
injection into the levator labii superioris alaeque nasi 
and the levator labii superioris, one site per muscle, 
2.5 unit per site. At one-week follow-up, we observed 
disappearance of the gummy smile and tightening 
of the nasal alar base as expected. However, an 
unusual complication was also noticed. A horizontal 
depression line appeared when the patient was 
smiling, and this became even more obvious when 
she was laughing (Figure 1C-E). This condition 
disappeared at the 3-month follow-up when the 
botulinum toxin type A effect resolved. 
 
Case Discussion 
The interest in ethnic cosmetic surgery has grown 
tremendously over the past decade, leading to 
various treatments of different anatomic regions 
Abstract 
Injections of botulinum toxin type A represent the 
most common nonsurgical cosmetic treatment 
worldwide. The authors report a case of dynamic 
horizontal wrinkling in the upper lip that appeared 
after botulinum toxin type A injections to treat 
gummy smile associated with nasal alar base 
reduction, in a 28-year-old woman. The anatomic 
features and pathogenic mechanism underlying this 
unusual complication are analyzed and discussed. 
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characterized by ethnic specific features, such as the 
gluteal region and the face [6-9]. In this regard, face 
rejuvenation with injectables or fillers certainly is one 
of the most relevant areas of interest for the cosmetic 
surgeon. Notably, treatment with botulinum toxin 
type A of the lower face in women specifically 
includes injections in the masseter muscle, the 
hypertrophy of which is possibly associated with a 
prominent mandibular angle leading to a square 
face [1]. In addition to this common indication, a 
growing request for dynamic wrinkles and gummy 
smile correction has also been reported [3-5, 10]. 
Gummy smile is effectively treated by injection of 
botulinum toxin type A into the levator labii 
superioris alaeque nasi and the levator labiaii 
superioris muscles, offering a safe treatment with 
low complication rate [11]. 
A similar approach is currently used in our practice to 
treat cases of excessive width of the nasal alar base. 
This condition is often associated with characteristics 
that create the gummy smile, which generally 
becomes more manifest during smiling and 
laughing. Alar base reduction can be indeed 
successfully achieved with the classical treatment for 
the gummy smile. Paralysis of these muscles is 
recommended for the desired and uneventful result. 
However, in the present case, we observed as a 
complication a horizontal depression line appearing 
when the patient was smiling, which became even 
more obvious when she was laughing. This was not 
previously reported in other articles on gummy smile 
and synkinesis treatment with botulinum toxin type 
A injections; generally, the major adverse effect is 
asymmetric smiling and oral motor insufficiency and 
pain [11].  
A possible explanation for this phenomenon may be 
the physiological dynamics of the smiling process, 
which indeed involves the levator labii superioris 
alaeque nasi, the levator labii superioris, the 
zygomaticus major and minor, and the risorius. 
These muscles work by pulling the upper lip in 
different directions: levator labii superioris alaeque 
nasi and levator labii superioris, superiorly, and the 
zygomaticus major and minor, superiolaterally. 
Instead, the risorius pulls the oral commissure 
laterally. In our case, the levator labii superioris  
 
Figure 1. Pre-treatment views of a 28-year-old Asian female patient with a complaint of gummy smile and excessive width of the nasal 
alar base, A) in static condition, and B) while smiling. Post-treatment views one month after botulinum toxin type A injection into the 
levator labii superioris alaeque nasi and the levator labii superioris. D) A horizontal depressing line is observed while the patient smiles, 
D-E) and becomes more evident while she laughs. A decrease in upper lip elevation is also noted in dynamic conditions. 
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alaeque nasi and the levator labii superioris were 
paralyzed. The risorius and the zygomaticus major 
muscles were still active after our injections, 
generating lateral pulling of the upper lip, which 
resulted in a thinning in the lower half of the upper 
lip. Meanwhile, the levator labii superioris alaeque 
nasi and the levator labii superioris failed to pull the 
upper part of the upper lip superiorly, resulting in a 
redundancy of labial tissue at this part during 
smiling. We therefore hypothesize that this resulting 
difference of tissue thickness in the upper and lower 
halves of the upper lip was responsible for 
determining the horizontal wrinkle when the patient 
was smiling or laughing. 
Conclusion 
Attention should be paid when reducing the nasal 
alar base or gummy smile or treating synkinesis with 
botulinum toxin type A injection.  A horizontal 
depression line could appear as a consequence of 
unevenly balanced lip elevator muscles. 
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